DJIA 17,826.30 -279.47 -1.54%
NASDAQ 4,931.82 -75.98 -1.52%
S&P 500 2,081.18 -23.81 -1.13%
market minute promo

STEMCELLS, INC. (NASDAQ: STEM)

0.91 -0.03 (-3.41%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

STEM $0.91 -3.41%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.94
Previous Close $0.94
Daily Range $0.90 - $0.95
52-Week Range $0.84 - $2.43
Market Cap $63.1M
P/E Ratio -1.81
Dividend (Yield) $0.00 (0.0%)
Volume 1,151,360
Average Daily Volume 624,509
Current FY EPS -$0.51

Sector

Healthcare

Industry

Drug Makers

STEMCELLS, INC. (STEM) Description

A biopharmaceutical company that operates in one segment, the development of novel cell-based therapeutics designed to treat human diseases and disorders. Website: http://www.stemcellsinc.com/

News & Commentary

Cloning: A Stem Cell Revolution?

Will the creation of cloned human stem cells create a treatment revolution and a profitable investment?

StemCells, Inc. Completes Enrollment of First Cohort in Phase II Pathway Study for Cervical Spinal C

StemCells, Inc. Completes Enrollment of First Cohort in Phase II Pathway Study for Cervical Spinal Cord Injury

Porat To Google Just One Of The Week's Top Management Changes; Here Are 7 More

Health Care Sector Update for 03/17/2015: STEM,ESPR,CNAT

Benzinga's Top #PreMarket Losers

StemCells' (STEM) CEO Martin McGlynn Discusses on Q4 2014 Results - Earnings Call Transcript

UPDATE: StemCells Posts Wider Q4 Net Loss

StemCells (STEM) Q4 2014 Results - Earnings Call Webcast

German Researchers Verify Positive, System-Wide Effect Of Pluristem's PLX Cell Therapy

Stem Cells Inc. Posts Letter to Shareholders

Monday's After-Hours Movers: Alcoa Kicks Off Earnings Season

See More STEM News...

STEM's Top Competitors

STEM $0.91 (-3.41%)
Current stock: STEM
AMGN $163.58 (-1.97%)
Current stock: AMGN
GILD $101.38 (-1.90%)
Current stock: GILD
BIIB $419.44 (-2.15%)
Current stock: BIIB